A major vaccine producer came under pressure following a report federal health regulators plan to tighten vaccine approval rules. Meanwhile, an agreement with the world's most valuable company bolster
A report that vaccine approvals could be set to get stricter is pressuring shares of major vaccine makers.
Major U.S. equities indexes lost ground Monday afternoon, as shares of tech and cryptocurrency-related companies pulled back. The S&P 500 and Nasdaq slid about 0.2%, while the Dow dropped 0.4%.
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock fell sharply on the news that the Food and Drug Administration (FDA) plans to implement stricter approval requirements for vaccines. The announcement raised
Memo also reportedly mentions vaccines for flu and pneumonia.
The FDA's top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock fell sharply on the news that the Food and Drug Administration (FDA) plans to implement stricter approval...
Stock News Airbus shares sink on fresh A320 quality snag: Airbus (EADSY) fell after reports of an industrial quality issue affecting fuselage panels on dozens o
FDA's new vaccine strategy tightens approval rules after internal findings linked COVID-19 shots to several child deaths.
While most eyes are on tech and chipmakers, biotech is quietly staging its biggest rally in over two decades.
AXQ Capital LP purchased a new stake in shares of Moderna, Inc. (NASDAQ: MRNA) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 10,099 shares of the comp
Moderna, Inc. ( MRNA ) Analyst/Investor Day November 20, 2025 9:00 AM EST Company Participants Stéphane Bancel - CEO & Director Stephen Hoge - President Jerh Collins - Chief Technical Operations & Qu
Creative Planning boosted its stake in Moderna, Inc. (NASDAQ: MRNA) by 19.4% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 107,593 shares of the compa
Washington reports world's first fatal human H5N5 bird flu case; officials say risk to public remains low, monitoring continues closely.
Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up to 10% revenue growth next year.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE